Search

Issue
Title
Authors
ENDOTHELIN RECEPTOR ANTAGONISTS IN PULMONARY HYPERTENSION TREATMENT
Shostak N.A., Klimenko A.A., Andriyashkina D.l., Demidova N.A.
Resistant arterial hypertension
Rodionov A.V., Yudin I.G., Fomin V.V.
Updated classification and diagnosis of pulmonary hypertension
Tsareva N.A.
Hypertension: from A.L.Myasnikov to the present
Chazova I.E.
THE PLACE OF RIOCIGUAT IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Platonov D.l., Iakovleva O.E., Bel'diev S.N., Il'in N.V., Tomskaia T.l., Ivanov K.I.
Modern approaches to the use of torasemide in cardiovascular diseases
Baryshnikova G.A., Chorbinskaya S.A., Stepanova I.I.
Prevention of stroke and dementia in high-risk patients
Ostroumova O.D.
The new 2018 European guidelines for the management of arterial hypertension: the most important aspects of use in real-life clinical practice
Ostroumova O.D., Kochetkov A.I.
Stenosis of the trunk of the left coronary artery in idiopathic pulmonary hypertension. Case report
Ivanov S.N., Edemskiy A.G., Vasiltseva O.Y., Chernyavskiy A.M., Kalashnikova M.V., Seletskaya S.V.
Diuretics in the treatment of arterial hypertension: the role of torasemide
Morozova T.E., Yudina I.Y.
Transcatheter sympathetic renal denervation for resistant arterial hypertension: the current state
Bolotov P.A., Semitko S.P., Klimov V.P., Vertkina N.V.
New possibilities in the treatment of hypertension
Chukaeva I.I., Ahmatova F.D.
An unusual case of respiratory failure in a patient with Randu–Osler–Weber disease. Case report
Podzolkov V.I., Pokrovskaya A.E., Ivanova V.S., Krylova K.E., Luchkina P.V., Murzakhanova F.E., Gerasimova D.D., Medvedev I.D.
Endocan is a key player in cardiovascular disease: A review
Alieva A.M., Reznik E.V., Baykova I.E., Teplova N.V., Makeeva L.M., Voronkova K.V., Khadzhieva N.K., Modestova A.V., Totolyan G.G., Valiev R.K., Li A.M., Kotikova I.A., Nikitin I.G.
Captopril in cardiological patients treatment: is there still place for the “first of the Mohicans”?
Valikulova F.Y., Koroleva L.Y., Melnichenko O.V., Duryndina E.M., Muradova F.N., Alekseeva M.M.
The use of renin-angiotensin system blockers in patients with COVID-19
Rodionov A.V.
Clinical case of a successful treatment of uncontrolled arterial hypertension in a 67-year-old patient with captopril
Pavlova T.V., Dupliakov D.V., Vorontsova S.A., Guseva G.N.
2018 AND 2019 GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION: IS THERE A PLACE FOR UNFIXED DRUG COMBINATIONS?
Pereverzev A.P., Ostroumova O.D.
OPPORTUNITIES OF CHRONOTHERAPY USE IN TREATMENT OF ARTERIAL HYPERTENSION AND COMORBID DISORDERS
Leonova M.V.
Algorithm for antihypertensive therapy choice: focus on candesartan
Shekhyan G.G., Yalymov A.A., Shchikota A.M., Timofeeva N.Y., Zadionchenko V.S., Terpigorev S.A., Nikishenkov A.M., Kabanova T.G.
Aspects of angiotensin receptor blockers use in hypertensive patients (focused on candesartan)
Evdokimova A.G., Kovalenko E.V., Evdokimov V.V., Tebloev K.I., Lobanova E.G.
Modern possibilities of treatment of arterial hypertension in elderly patients
Chukaeva I.I., Spiryakina Y.G., Litvinova S.N., Shterengas A.V., Denisova N.N.
Chronic vascular diseases of the brain: an algorithm for diagnosis and treatment
Shakhparonova N.V., Kadykov A.S.
Psychological characteristics of patients with stress-induced arterial hypertension: emotion dysregulation is the central component in the pathogenesis
Pervichko E.I., Ostroumova O.D., Zinchenko Y.P.
Guidelines for intensive care in non-traumatic subarachnoid haemorrhage cases (review)
Rudnik E.N., Belkin A.A.
Azilsartan medoxomil/chlorthalidone combination therapy: new prospects in light of SPRINT, HOPE-3 and ACCORDION trials
Nedogoda S.V.
Age aspects of -adrenergic blocking agents dosing in arterial hypertension treatment using Bisoprolol application as an example
Savenkov M.P., Ivanov S.N., Shtandel L.N., Savenkova A.M., Postnikova Z.V.
Systemic inflammation and endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with hypertension: review of the literature and our own data
Ovcharenko S.I., Nersesian Z.N.
Acetylsalicylic acid in hypertensive patients at high risk
Vorobyeva N.M.
Comparative assessment of arterial stiffness and endothelial dysfunction during treatment with fixed combinations of antihypertensive drugs in patients with arterial hypertension and coronary artery disease
Khakuasheva I.А., Umetov M.A., Urusbieva J.M., Abukova A.K., Didanova L.A.
The role of stress and sleep disorders in the development of cardiovascular complications in patients with arterial hypertension: what is important for an internist to know? A review
Ionin V.A.
Potassium and magnesium deficiency, its role in cardiovascular disease development and possibilities of correction
Baryshnikova G.A., Chorbinskaya S.A., Stepanova I.I., Blokhina O.E.
Features of gestation, childbirth and the state of health of newborns in pre-pregnant women with chronic arterial hypertension
Petrov Y.A., Podgorny I.V., Chebotaryova Y.Y., Podgorny G.I.
Statins in certain patient populations: scientific evidence and algorithms for practicing physicians
Susekov A.V.
Cardiology: genetics’ time
Sonicheva N.A., Zateyshchikov D.A.
WHICH ASPECTS ARE THE MOST SIGNIFICANT IN RUSSIAN AND EUROPEAN GUIDELINES? INTERVIEW
Triple drug combinations in cardiology
Arutiunov A.G., Dragunov D.O., Sokolova A.V.
Asthma and cardiovascular disease
Ostroumova O.D., Goloborodova I.V., Voevodina N.Y., Fomina V.M., Seregin A.A.
The evolution of mineralocorticoid receptor antagonists: spironolactone and eplerenone
Leonova M.V., Alimova E.E., Eremina Y.N.
New opportunities to treat patients with high cardiovascular risk
Baryshnikova G.A., Chorbinskaya S.A.
Psychopharmacological support in a situation to cope with stress in hypertensive patients with anxiety disorders
Garganeeva N.P., Belokrylova M.F., Epanchinceva E.M.
Angiotensin II receptor antagonist - candesartan in the arsenal of therapist
Kirichenko A.A.
Pulmonary thromboendarterectomy: state of the problem
Akchurin R.S., Mershin K.V., Lepilin M.G., Korolev S.V., Tabakian E.A.
The differential diagnosis of neurological disorders in patients with arterial hypertension
Vakhnina N.N.
Risk of hypertension development in patientswith oncological diseases under anticancer treatment
Chazova I.E., Oshchepkova E.V., Kirillova M.Y., Stenina M.B.
Combined therapy in hypertension: a new fixed-dose combination of angiotensin II receptor blockers and diuretics (azilsartan medoxomil and chlorthalidone)
Ostroumova O.D., Fomina V.M.
Efficacy and safety in clinical practice fosinopril
Stryuk R.I.
Obstructive sleep apnea and hypertension: The state of the problem from the eyes of a somnologist. Case report
Palman А.D., Shishkin R.K.
The prevalence of hypertension among patients with psoriasis in clinical practice
Kuzmina O.A., Mironova O.I., Lepekhova A.A., Fomin V.V.
Sartans in hypertension treatment: advantages of candesartan use
Leonova M.V.
Chronic kidney disease: risks to mother and fetus (literature review)
Kupina A.D., Petrov Y.A.
Cerebral edema: from the origins of the description to the modern understanding of the process
Gudkova V.V., Kimelfeld E.I., Belov S.E., Koltsova E.A., Stakhovskaya L.V.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: A CHOICE OF THE DRUG IN CLINICAL PRACTICE GIVEN THE EFFECTIVENESS AND SAFETY OF USE
Mubarakshina O.A., Liubavskaia S.S., Somova M.N., Batishcheva G.A.
Fixed combination of perindopril and bisoprolol in cardiovascular disease treatment
Baryshnikova G.A., Chorbinskaya S.A., Stepanova I.I., Blohina O.E.
Side effects of non-steroidal anti-inflammatory drugs
Dyadyk A.I., Kugler T.E.
Migraine and cerebrovascular pathology: a review of the literature and experience overview of using candesartan for the prevention of migraine in patients with arterial hypertension
Azimova Y.E., Skorobogatykh K.V., Ishchenko K.A., Klimov E.A.
Polypill in the prevention of cardiovascular diseases: evidence base, limitations and prospects (based on the report of the European Society for Hypertension)
Morozova T.E., Yudina I.Y., Karnoukh K.I., Shatskiy D.A.
Heart damage in arterial hypertension. Management of hypertension and contractile dysfunction
Gurevich M.A., Kuzmenko N.A.
Calcium channel blockers in cardioprotection and nephroprotection: with a focus on lercanidipine
Evdokimova A.G., Ryzhova Y.V., Tebloev K.I., Shuyskaya O.A.
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Danilov N.M., Matchin Y.G., Chazova I.E.
Rational choice of combination antihypertensive therapy
Morozova T.E., Gontarenko S.V.
Arterial hypertension and the kidney
Chikhladze N.M., Chazova I.E.
Preimushchestva fiksirovannoy kombinirovannoy antigipertenzivnoy terapii u bol'nykh s tserebrovaskulyarnoy patologiey: fokus na kombinatsii «bisoprolol + amlodipin»
Evdokimova A.G., Markova L.I., Evdokimov V.V., Arkad’eva G.V.
Possibilities of noninvasive diagnostics of cardiovascular diseases associated with atherosclerosis
Salyamova L.I., Pavlenko K.I., Khromova A.A., Oleynikov V.E.
Combination therapy of newly diagnosed intermediate-risk pulmonary arterial hypertension: A review
Lyapina I.N., Zvereva T.N., Martynyuk T.V.
The possibility of the blood pressure control at the outpatient stage
Larina V.N., Fedorova E.V., Sidorova V.P., Kladovikova O.V.
Tactics of management of patients with cardiovascular diseases. Roundtable report
Konradi A.O., Baranova E.I., Gurevich V.S., Zvartau N.E., Konstantinov V.O., Nifontov E.M., Obrezan A.G., Panov A.V., Sitnikova M.Y.
MILDRONATE USE IN COMPLEX TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ITS INFLUENCE ON HEART AND VESSELS MORPHOFUNCTIONAL STATE
Mikhin V.P., Khlebodarov F.E., Vasil'eva D.A., Gromnatskii N.I.
STUDY OF A FIXED COMBINATION OF LISINOPRIL, LONG-ACTING INDAPAMIDE AND AMLODIPINE USING DAILY BLOOD PRESSURE AND DIURESIS MONITORING IN PATIENTS WITH ARTERIAL HYPERTENSION
Savenkov M.P., Ivanov S.N., Mikhailusova M.P., Palkin M.N., Okuneva I.N., Ivanova S.V.
Edema pharmacotherapy in patients with hepatic cirrhosis and congestive heart failure: loop diuretics in focus
Ketova G.G., Popov A.Y., Babich A.E., Luchinina E.V.
The role of endothelin-1 receptor antagonist bosentan in the treatment of pulmonary hypertension
Shostak N.A., Klimenko A.A., Demidova N.A.
The importance of polymorphisms of the ABCB1 and CYP3A5 genes in predicting the efficacy and safety of amlodipine in patients with arterial hypertension of 1-2 degree
Morozova T.E., Shikh N.V., Sychev D.A., Kalle E.G., Rigikova K.A.
Blood pressure indices and sleep quality in elderly patients with chronic cerebral ischemia and arterial hypertension on the background of treatment with Pantocalcin (gopanthenic acid). The results of the PLATON noninterventional observational program
Kamchatnov P.R., Azimova Y.E., Ostroumova O.D.
Pharmacological validity of amlodipine, lisinopril and rosuvastatin in three-component combination drug products
Giliarevskiy S.R., Golshmid M.V., Kuzmina I.M., Zakharova G.Y., Sinitsina I.I.
On the way to optimization approach for the treatment of chronic thromboembolic pulmonary hypertension
Martyniuk T.V., Nakonechnikov S.N., Chazova I.E.
Angiotensin-converting enzyme inhibitors - the risk of dementia and possibilities of improving cognitive functions:the unique characteristics of perindopril
Ostroumova O.D., Galeeva N.Y., Bondarets O.V., Guseva T.F., Kopchenov I.I.
Principles of selection of a fixed combination antihypertensive agents
Morozova T.E., Andrushchishina T.B., Andreev S.S., Chukina M.A.
Mineralocorticoid receptor antagonists: a dubious past and advanced future
Napalkov D.A.
Arterial hypertension and cognitive function
Ostroumova O.D., Dudaev V.A., Galeeva N.Y.
Effectiveness and tolerability of fixed-dose combinations of telmisartan in patients with hypertension with metabolic syndrome and without metabolic changes
Napalkov D.A.
On the issue of low adherence of patients to antihypertensive therapy: the use of therapeutic drug monitoring of drugs: A review
Leonova M.V.
Modern strategy in the treatment of arterial hypertension: combination therapy and fixed combinations
Leonova M.V.
Hyperuricemia in patients with stable coronary artery disease and arterial hypertension and percutaneous coronary interventions
Mironova O.l., Fomin V.V.
HEART RHYTHM DISORDERS AND TOTAL CARDIOVASCULAR RISK AMONG MEMBERS OF LOCOMOTIVE CREWS WITH ARTERIAL HYPERTENSION
Metso K.V., Nikiforov V.S.
Antihypertensive therapy in patients with diabetes mellitus and chronic kidney disease specifications: the perspective of modern European guidelines 2018
Ostroumova O.D., Goloborodova I.V.
Chronic obstructive pulmonary disease and comorbid cardiovascular disease: in the context of guidelines
Ostroumova O.D., Kochetkov A.I.
Choice of calcium channel blockers in arterial hypertension. Pharmacokinetic and pharmacodynamic mechanisms of high selectivity and superlative action of lercanidipine
Morozova T.E., Vartanova O.A.
Features therapy of cardiovascular diseases during heat waves
Smirnova M.D., Ageev F.T.
The role of the genetic polymorphism determination in arterial hypertension pathogenesis with the aim of individualization medical therapy
Drobotya N.V., Arutyunyan L.V., Pirozhenko A.A.
Prevention of stroke, cognitive impairment and dementia in patients with hypertension during the provision of primary health care
Trukhan D.I., Davydov E.L.
Clinical aspects of application of candesartan
Rybachkova Y.V.
The Contemporary History of the drug therapy in patients with arterial hypertension: is antihypertensive therapy only one way of treating?
Giliarevskii S.R., Golshmid M.V., Kuzmina I.M., Zakharova G.Y., Sinitsina I.I.
Transluminal balloon angioplasty of pulmonary arteries in patients with inoperable chronic thromboembolic pulmonary hypertension (first experience in Russia)
Danilov N.M., Matchin Y.G., Martynyuk T.V., Fedotenkov I.S., Chazova I.E.
Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship
Litvin A.Y., Mikhailova O.O., Elfimova E.M., Bugaev T.D., Chazova I.E.
The application of calcium channel blockers in patients with cardiovascular disease: focus on the diltiazem
Zadionchenko V.S., Shehyan G.G., Yalymov A.A., Schikota A.M., Sherstyannikova O.M., Asymbekova E.U.
Optimization of blood pressure control in patients with resistant arterial hypertension and visceral obesity
Deneka I.E., Rodionov A.V., Fomin V.V.
Subclinical hypothyroidizm and essential arterial hypertension: features of daily profiles of arterial stiffness in comorbid patients
Andreeva L.A., Panchenkova L.A., Troshina E.A., Khamidova K.A., Gagieva A.M.
Experience of using a fixed combination of ramipril and indapamide in clinical practice
Kochetkova I.V.
P2-ADRENERGIC RECEPTORS GENETIC POLYMORPHISM, CARDIOVASCULAR DISORDERS AND INFLUENCE OF P-BLOCKERS’ EFFECTIVENESS
Leonova M.V.
Pulmonary hypertension and chronic kidney disease: prevalence, potential mechanisms and treatment
Rudenko T.E., Vasilyeva M.P., Bobkova I.N.
1 - 100 of 141 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».